Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

Luca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, Carlo Albera, David J Lederer, Kevin R Flaherty, Neil Ettinger, Rafael Perez, Mary Beth Scholand, Jonathan Goldin, Kin-Hung Peony Yu, Thomas Neff, Seth Porter, Ming Zhong, Eduard Gorina, Elias Kouchakji, Ganesh Raghu

Risultato della ricerca: Contributo in rivistaArticolo in rivista

39 Citazioni (Scopus)

Fingerprint Entra nei temi di ricerca di 'Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial'. Insieme formano una fingerprint unica.

Medicine & Life Sciences